Merrimack Pharmaceuticals, Inc. (MACK) - Earnings & Price History

MACK: Merrimack Pharmaceuticals, Inc. - 11.16, $156.96M, -0.58 (-4.94%)

Sector: Healthcare - Industry: Biotechnology

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. The company offers ONIVYDE that is used for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. Its therapeutic oncology candidates in clinical development include MM-398, which is in Phase II clinical trials for the treatment of patients with previously untreated, metastatic pancreatic adenocarcinoma; Phase I clinical trials for the treatment of patients with glioma, pediatric solid tumors, and gastrointestinal tumors; and Phase I clinical trials for treating metastatic breast cancer. The companys therapeutic oncology candidates also include MM-302 that is in Phase

Past MACK reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-01BMO-0.212.9753.073.152.93.152.61%-5.56%-3.09%5.34M
2016-11-09AMC-0.276.465.9165.836.731.52%▲7.67%9.31%8.19M
2016-08-04AMC-0.335.525.925.55.285.69-7.09%0.36%-6.76%4.45M
2016-05-02AMC-0.386.677.286.876.427.06-5.63%-2.91%-8.38%3.43M
2016-02-25AMC-0.315.565.385.225.185.89-2.97%6.51%3.35%3.51M
2015-11-09AMC-0.48.939.829.528.669.66-3.05%▲-6.20%-9.06%2.10M
2015-08-10AMC-0.3110.089.539.759.711.182.31%3.38%5.77%3.55M
2015-05-07-0.2911.411.211.210.9911.531.79%1.79%1.25M
2015-04-28BMO-0.2912.1512.2712.3211.9112.80.41%-1.38%-0.98%1.86M
2015-04-27BMO-0.2912.27513.4213.8412.2513.843.13%-11.31%-8.53%2.41M
2015-02-26BMO-0.1910.7710.8511.0210.2411.191.57%-2.27%-0.74%1.32M
2014-11-10AMCMerrimack Phar0.08-0.278.358.78.278.18.7-4.94%▲0.97%-4.02%4.25M
2014-08-11BMOMerrimack Phar-0.32-0.176.76.536.976.686.996.74%-3.87%2.60%2.78M
2014-05-12Merrimack Phar-0.31-0.276.636.776.746.636.94-0.44%-1.63%-2.07%1.52M
2014-02-27AMCMerrimack Phar-0.34-0.334.985.064.954.785.25-2.17%0.61%-1.58%2.04M
2013-11-07BMOMerrimack Phar-0.34-0.392.562.062.32.252.8711.65%▲11.30%24.27%7.93M
2013-08-08BMOMerrimack Phar-0.29-0.313.954.64.623.814.630.43%-14.50%-14.13%6.09M
2013-05-13-0.285.535.175.215.155.640.77%6.14%6.96%652.54K
2013-03-14BMO-0.266.156.346.346.146.42-3.00%-3.00%275.92K
2012-11-14-0.267.13956.877.056.757.242.62%▲1.27%3.92%983.40K
2012-08-10BMOQ2 2012 Merrimack Ph-0.27-0.227.387.377.377.337.690.14%0.14%53.40K
2012-05-15Q1 2012 Merrimack Ph-0.22-2.147.377.057.127.127.390.99%3.51%4.54%190.00K

Login | Register
Saturday Nov 17, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades